CureTech Innovative Therapies
Keller Douglas, MBA, has a diverse professional background in finance and sales, currently serving as a Medical Device Sales Associate at CureTech Innovative Therapies since May 2024. Prior experience includes working as an Account Executive at Paycom from February 2023 to May 2024 and serving as Chief Financial Officer at Children's International Pediatrics between April 2021 and February 2023. Keller's earlier roles involved tax accounting and consulting at Kushner LaGraize, L.L.C., and Patrick Gros, CPA. Academic credentials include a Master of Business Administration in Accounting from Southeastern Louisiana University and a Bachelor's degree in Accounting from Spring Hill College.
This person is not in any teams
CureTech Innovative Therapies
The market leader of mobile DVT Prevention and Cryo-Compression solutions. With a mission to improve patient outcomes and provider satisfaction scores, CureTech's customizable ASC/Clinic programs quickly became physician's #1 choice for post-op recovery & preventative therapies. With the belief that healthcare needed to be reimagined, CureTech was created. CureTech believes that the “patient experience” starts first by creating the perfect “rep experience”. By focusing on our people, with a shared passion of changing the patient experience after surgical intervention. By focusing on patient satisfaction, preventing post surgical complications, alleviating opioids, and accelerating recovery, CureTech’s vision came to life in large part to our amazing physicians, ASCs, and coast-to-coast distributor partners! In short time, CureTech has become one the nation’s largest and most trusted Durable Medical Equipment (DME) suppliers with representation in 32 states. Offices located in Kentucky, Tennessee and Texas. Awarded: 2024 Best Places to Work 2023 #1 Supplier of the Year 2022 #2 Fastest Growing Company, KY 2022 #1 Supplier of the Year